Keywords: BMP, bone morphogenic protein; CML, chronic myeloid leukemia; TKI, tyrosine kinase inhibitor; VIC, valvular interstitial cell; aortic stenosis; leukemia; nilotinib; tyrosine kinase inhibitor; valvular disease.